Trade Allakos Inc. - ALLK CFD

Add to favourite

0.27

1.84%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.04

Long position overnight fee

-0.023512%

Short position overnight fee

0.00129%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.2713
Open	0.2705
1-Year Change	-77.64%
Day's Range	0.26 - 0.2707

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 21, 2025	0.2663	-0.0012	-0.45%	0.2675	0.2708	0.2599
Feb 20, 2025	0.2713	0.0048	1.80%	0.2665	0.2788	0.2651
Feb 19, 2025	0.2740	-0.0103	-3.62%	0.2843	0.2851	0.2658
Feb 18, 2025	0.2922	0.0136	4.88%	0.2786	0.3037	0.2718
Feb 14, 2025	0.2943	0.0281	10.56%	0.2662	0.2987	0.2571
Feb 13, 2025	0.2770	0.0323	13.20%	0.2447	0.2775	0.2371
Feb 12, 2025	0.2452	0.0028	1.16%	0.2424	0.2470	0.2351
Jan 31, 2025	0.2200	0.0000	0.00%	0.2200	0.2400	0.2200
Jan 30, 2025	0.2200	0.0000	0.00%	0.2200	0.2200	0.2200
Jan 29, 2025	0.2300	0.0000	0.00%	0.2300	0.2300	0.2200
Jan 28, 2025	0.2400	0.0000	0.00%	0.2400	0.2400	0.2200
Jan 27, 2025	0.2200	-0.0100	-4.35%	0.2300	0.2800	0.2100
Jan 24, 2025	1.1800	0.1300	12.38%	1.0500	1.2300	1.0200
Jan 23, 2025	1.0100	-0.0500	-4.72%	1.0600	1.0800	0.9700
Jan 22, 2025	1.0900	-0.0300	-2.68%	1.1200	1.1300	1.0100
Jan 21, 2025	1.0800	0.1700	18.68%	0.9100	1.1200	0.9100
Jan 17, 2025	0.8300	-0.1400	-14.43%	0.9700	1.1200	0.8200
Jan 16, 2025	0.8900	0.0500	5.95%	0.8400	0.9900	0.7800
Jan 15, 2025	0.8400	-0.0100	-1.18%	0.8500	0.8800	0.8300
Jan 14, 2025	0.8500	-0.0600	-6.59%	0.9100	0.9300	0.8300

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Allakos Inc. Company profile

About Allakos Inc

Allakos Inc. is a clinical stage biotechnology company. The Company is developing therapeutics, which target immunomodulatory receptors present on immune effector cells involved in allergy, inflammatory, and proliferative diseases. Its advanced antibodies are lirentelimab (AK002) and AK006. AK002 selectively targets both mast cells and eosinophils, two types of white blood cells that are widely distributed in the body and play a central role in the inflammatory response. It is developing AK002 for the treatment of eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), eosinophilic duodenitis (EoD), atopic dermatitis, chronic spontaneous urticaria and additional indications. AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. It also developed a formulation of lirentelimab for subcutaneous (SC) administration. The Company is also developing additional antibodies targeting inhibitory receptors expressed on key disease-driving immune cells.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Allakos Inc revenues was not reported. Net loss increased 76% to $269.9M. Higher net loss reflects Research and Development - Balancing increase of 88% to $176.5M (expense), General and Administrative - Balancing increase of 49% to $44.2M (expense), Stock-based Compensation in SGA increase of 42% to $31M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$3.10 to -$5.01.

Industry:

Bio Therapeutic Drugs

825 Industrial Road
Suite 500
SAN CARLOS
CALIFORNIA 94070
US

News

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025